Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutational activation of FGFR3 is not involved in the development of prostate cancer.

Pathobiology : journal of immunopathology, molecular and cellular biology - 1 Jan 2010

Koufou Stella, Lunz Jens-Claudio, Borchardt Albert, Keck Bastian, Kneitz Burkhard, Gaisa Nadine T, Hafner Christian, Giedl Christian, Rau Tilman T, Rogler Anja, Wieland Wolf F, Hartmann Arndt, Stoehr Robert

Abstract excerpt

OBJECTIVE: The mutational constitutive activation of FGFR3 has been discovered in several malignancies but only limited data on FGFR3 mutations in prostate cancer are available. Most recently, activating FGFR3 mutations were described as being associated with low-grade prostate tumors. Therefore,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to FGFR3 gene

Share to Mutation

Share to Polymorphism, Restriction Fragment Length

Share to Prostatic Neoplasms

Share to Receptor, Fibroblast Growth Factor, Type 3

Source

Identifiers

PMID: 21116115
DOI: 10.1159/000317055

Genes

FGFR3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21116115-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Mutational activation of FGFR3 is not involved in the development of prostate cancer.PMID 21116115Read ↗

FGFR3 mutations in prostate cancer: association with low-grade tumors.Semantic proximity Read ↗

No evidence of FGFR3 mutations in prostate cancer.Semantic proximity Read ↗

No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer.Semantic proximity Read ↗

Fibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations.Semantic proximity Read ↗

[Correlation of FGFR3 mutations and chromosomal alterations in bladder cancer].Semantic proximity Read ↗

Fibroblast growth factor receptor-2 mutation analysis in human prostate cancer.Semantic proximity Read ↗

Occupational exposure to polycyclic aromatic hydrocarbons influenced neither the frequency nor the spectrum of FGFR3 mutations in bladder urothelial carcinoma.Semantic proximity Read ↗

Kruppel-like factor 6 germ-line mutations are infrequent in Finnish hereditary prostate cancer.Semantic proximity Read ↗

Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.Semantic proximity Read ↗

Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder.Semantic proximity Read ↗

Lack of BRAF activating mutations in prostate adenocarcinoma: a study of 93 cases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.